FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction

FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction

Show other versions (1)

Background: Fibroblast growth factor 23 (FGF23) is known to cause left ventricular hypertrophy (LVH), but controversy exists concerning its effect in dialysis. This study evaluated associations between FGF23 levels, echocardiography and prognosis in patients on hemodialysis (HD). Methods: Patients &...

Full description

Bibliographic Details
Main Authors: Ture Lange Nielsen, Louis Lind Plesner, Peder Emil Warming, Ole Hartvig Mortensen, Kasper Karmark Iversen, James Goya Heaf
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Nefrología (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2013251419300793

Internet

http://www.sciencedirect.com/science/article/pii/S2013251419300793

Similar Items